|
BIOSTEM TECHNOLOGIES INC.
US SYMBOL: BSEM
Last Price: 4.00 | Website | Latest News
Good Morning Ggg,
Today's alert absolute MUST to have on your radar. We're looking at an OTC MedTech company with $301 MILLION in revenue and KMPG, one of the "Big Four" accounting firms asssiting it's push toward the NASDAQ. If you haven't read our full alert yet, scroll down now to see a chart that's screaming "BOUNCE".
Operating in the MedTech space with cutting-edge regenerative medicine, ROARING REVENUE GROWTH, and a unique Bottom Bounce Chart now tightening into place, this setup is demanding attention.
WE ARE ISSUING AN IMMEDIATE ALERT ON BSEM!
The future is regenerative medicine and BioStem Technologies (OTC: BSEM) is leading the way with innovation, exploding revenues, and breakthrough achievements!
This growing Medtech company is harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies in advanced wound care. BSEM is focused on manufacturing products that change lives, leveraging its proprietary BioREtain® processing method.
BSEM manufactures perinatal tissue allografts at the highest levels of quality, leveraging their BioREtain method to focus on maintaining natural growth factors and preserving tissue structure.
BSEM's allografts, including VENDAJE®, VENDAJE AC®, VENDAJE OPTIC® and AmnioWrap2TM are trusted by top clinicians across a range of specialties.
So it should come as no wonder why BSEM has seen Revenues EXPLODE and why there's so much talk of a NASDAQ UPLIST....
In just the last year alone, BSEM generated over $301 MILLION DOLLARS in Revenues compared to $16.6 Million the previous year. That's a 1,857% INCREASE!!
Now compared to 2021 - that's a 6,855% REVENUE BOOM in just 4 years!!
Talk about SUCCESS!!
Yet BSEM still trades on the OTC Markets at around a mere $4.00 with 382% UPSIDE at its 52-week high of $19.28.
BSEM, recently appointed KPMG - one of the Big Four accounting firms - as its new independent auditor and is actively pursing uplisting to NASDAQ. This makes perfect sense... a company with MASSIVE Revenues like this should be trading with the big boys!
Even BSEM's CEO has LOADED UP on shares!!
BSEM POISED FOR A BOUNCE?
Even though BSEM's 2nd Quarter Earnings were phenomenal, the market reacted poorly to some insight from the company about increased competition.
What we are looking at here, appears to scream "BOUNCE".
If you read our previous alert on BSEM, we called out a "Falling Wedge Pattern" which consolidated at exactly $4.00, the same price BSEM closed today. Since that previous alert in October, we have seen the stock not just stabilize, but consolidate at this price.
WHAT IS A BOTTOM BOUNCE STOCK?
A temporary or full recovery/reversal from a prolonged decline or bear market. A bounce could be a small, short-lived recovery in the price of a declining security or signal a full reversal of the price. Frequently, downtrends are interrupted by brief periods of recovery - or small rallies - where prices temporarily rise. This can be a result of traders or investors closing out short positions or buying on the assumption that the security has reached a bottom. |
|
BSEM also sits just under both the 50 (red line) and 20 Day (blue line) Moving Averages resistance which means a breach through BOTH could confirm a Bullish Sequence!
Not to mention, our MACD Indicator may CONFIRM A MOMENTUM SHIFT and still continues to trend up even while BSEM has traded sideways, indicating growing buying pressure.
When charts tighten like this, they often resolve with sharp moves.
Keep in mind, a return to its 52-week high of 19.28 would generate 382% GAINS!
THE BOTTOM LINE
We don't see setups like this every day. A MedTech company with Record-Breaking Revenue Growth to the tune of $301 MILLION yet still trades on the OTC?
With KPMG, one of the "BIG FOUR" accounting giants helping push toward a NASDAQ uplisting... it may not be long before this $4 play goes mainstream!
Keep in mind, BSEM's CEO is also BUYING more shares of BSEM at these low prices!!
Needless to say, Bottom-Bounce situations, with potential NASDAQ uplists don't come around often. You're going to want to have BSEM on your radar BEFORE it goes mainstream!
Make sure you put it on your screen RIGHT NOW and
Follow on Twitter for Updates + Play-by-Play!
|
